Medicare AdvantageCoverageMedium impact
MA08.149a, Inclisiran (Leqvio®)
Independence Blue Cross·Cardiology, Endocrinology, Internal Medicine +1 more·Pharmacy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA08.149a for Inclisiran (Leqvio®) has been updated with new coverage or authorization requirements. This affects pharmacy billing for this cholesterol-lowering medication used in cardiovascular care.
Action Required
By October 1, 2025: Billing and clinical teams must review updated MA08.149a policy for Inclisiran (Leqvio®) coverage requirements. Access the full policy details at the IBX medical policy site to understand new prior authorization, documentation, or coverage criteria. Update billing protocols and provider workflows accordingly for Medicare Advantage patients requiring this medication.